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Abstract: Lipases, a versatile class of biocatalysts, have been shown to function in non-aqueous
media/organic solvents and to possess “promiscuous” catalytic activity for a wide range of organic
transformations. In this study, we explored the biocatalytic properties of a library of commercially
available lipases by screening them for catalysis of a one-pot synthesis of Wieland–Miescher ketone,
an important intermediate in the synthesis of biologically active compounds such as steroids and
terpenoids, from methyl vinyl ketone and 2-methyl-1,3-cyclohexanedione. As a direct outgrowth
of this screen, we created an optimized procedure for Wieland–Miescher ketone (WMK) synthesis
using crude lipase preparations, characterizing both reaction yield and enantiomeric excess. We also
identified principal components of the crude lipase mixture through proteomics and present evidence
for a non-lipolytic origin of the observed catalysis. Finally, using the optimized conditions developed
in this study, we propose a general absorbance-based screening methodology for assessing biocatalytic
potential of crude enzyme preparations for synthesis of WMK.
Keywords: lipase; biocatalysis; Wieland-Miescher ketone; biocatalyst screening; amylase; peptidase;
enantiomeric excess; Robinson annulation
1. Introduction
Metal-based catalysts have revolutionized synthetic chemistry, enabling challenging chemical
reactions with exquisite stereochemical control [1,2]. Disadvantages of their frequent use, however,
include high cost and potentially adverse environmental effects. As a result, chemists have explored
biologically derived catalysts as less expensive and less toxic alternatives [1–4]. In particular,
the pharmaceutical industry has adapted biocatalysts to “green” large-scale synthetic pathways [3].
Numerous enzymes, for example, have been evolved to synthesize pharmaceutical compounds, or their
intermediates, with high yields and enantiomeric excess, improving overall process efficiency and
environmental compatibility [4].
Lipases, a versatile class of biocatalysts, have undergone extensive study over the past
two decades [5]. They have been reported to function in non-aqueous media/organic solvents,
possess catalytic activity towards a wide range of organic reactions, and provide recyclability via
immobilization [1,5–7]. In their native (biological) setting, lipases catalyze the hydrolysis of esters from
triacylglycerides. However, when placed under minimal or no-water conditions, they can catalyze
various types of organic transformations such as Michael additions and aldol additions [6,8]. Catalysis
of these non-native transformations by enzymes has been previously deemed “promiscuous” [9,10],
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a general descriptor for proteins that catalyze non-native transformations. Hult and Berglund
previously defined three types of promiscuity: conditional (due to change in solvent, temperature, etc.);
substrate (adaptable substrate specificity); and catalytic (accommodation of mechanistically distinct
reactions) [9]. The catalytic promiscuity of lipases has been the foundation on which various studies
have been conducted to demonstrate a broad spectrum of lipase catalyzed organic transformations
including the Robinson annulation, the Knoevenagel condensation, and the Morita–Baylis–Hillman
reaction [7,11,12]. Lipases derived from plant, animal, and fungal sources, or recombinantly expressed
from a variety of host organisms, are readily commercially available and thus are an attractive source
of new catalytic moieties.
Despite intensive investigation of lipase biocatalysis, unanswered questions remain regarding
fundamental aspects of their propensity for promiscuous catalysis [13]. Some studies have identified
crude lipase preparations with biocatalytic properties presuming, but not demonstrating, that lipase,
in particular the lipase active site responsible for the in vivo hydrolysis of fatty acids (Figure 1A,B),
is also responsible for promiscuous biocatalytic behavior observed in organic or aqueous/organic
solvent mixtures (Figure 1C) [12,14]. While in many instances the lipase activity present in crude lipase
preparations is directly responsible for promiscuous catalysis, this is not always the case [15,16]. In the
absence of a more thorough characterization of these catalytic moieties, it is challenging to improve on
the initial findings through the now-standard means of rational design and/or directed evolution.
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Figure 1. Porcine pancreatic lipase (PPL) is a model lipase for biocatalysis of C-C bond forming reactions.
The active site ((A) colored spheres) of PPL is presumed to catalyze the C-C bond forming reactions via
carbonyl binding and activation in an oxy-anion hole. The lid domain ((A) red ribbon) is presu ed
to undergo interfacial activation (assuming an open conformation in more hydrophobic solvents).
(B) Both lid domain and active shown in context of 3D protein ribbon structure (PDB ID 1ETH).
(C) Examples of carbon-carbon bond forming reactions catalyzed by lipases (Robinson annulation:
reaction of cyclohexanedione 1 and methyl vinyl ketone 2 provides bicyclic Wieland–Miescher ketone
products 3 and 4; Morita–Baylis–Hillman: reaction of dinitrobenzaldehyde 5 and cyclohexenone
6 provides MBH products 7 and 8; and Knoevenagel condensation: reaction of 2-oxindole 9 and
nitrobenzaldehyde 10 provides KC products 11 and 12). (D) Overview of screening methodology.
Biocatalytic reactions were scaled down but otherwise conducted according to literature procedures.
Mass spectrometry methodologies (LC/MS and MALDI) were used to screen the resulting biocatalytic
reactions for product formation. Commercially available compounds were purchased for use as
standards in mass spec calibration. Screening was then followed by reaction optimization and
measurement of yield and stereoselectivity.
Our approach to the characterization of biocatalysts involved screening crude preparations for
biocatalytic activity with mass spectrometry followed by reaction optimization (Figure 1D). In addition,
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we utilized mass spectrometry for identification of the primary components of biocatalytic lipase
preparations. This opens the possibility of improving reproducibility and further development of
biocatalytic methods. In this work, we describe methods to screen lipase preparations for biocatalytic
activity towards a synthetically useful target, the Wieland–Miescher ketone (3 and 4, Figure 1C),
an important intermediate for the synthesis of biologically active compounds such as steroids,
terpenoids, and taxol, via a one-pot Robinson annulation reaction. In the Robinson annulation,
a Michael addition between a ketone and a methyl vinyl ketone is followed by an intramolecular
aldol condensation to form a six-membered ring. We also describe how initial results from a mass
spectrometry-based screen can be improved through a process of reaction optimization. We took
lead catalysts from the screen and further characterized their proteinaceous components, identifying
non-lipase proteins that are potentially responsible for the observed catalytic activity. The methodology
and fundamental characterization of biocatalysts described in this report have general utility in the
screening and identification of biocatalysts in numerous organic transformations.
2. Results
We began by assembling a 14-member library of commercially available lipases preparations,
selecting lipases previously reported to catalyze C-C bond forming reactions (porcine pancreatic
lipase, Candida antarctica lipase B) [11,12,14,17], in addition to lipase preparations with unknown
biocatalytic properties in promiscuous biocatalysis (Wheat germ lipase). Biocatalytic potential of the
lipase library was then assessed for synthesis of the Wieland–Miescher ketone from methyl vinyl ketone
and 2-methyl-1,3-cyclohexanedione using recently reported literature conditions [12]. To rapidly assess
biocatalytic potential of the library, an LC/MS method was developed (Materials and Methods) that
detected only the main fragmentation pattern Wieland–Miescher ketone product (Figure 2).
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Figure 2. evelop ent of an L / S ethod for biocatalyst screening. ( ) L / S data for standard
(upper left) and lipases L1, L3, and L7 (clock ise fro upper right). (B) Standard curve for Robinson
annulation product (3 and 4) generated ith LC/ S ethod. (C) Quantification of data for lipase
library using standard curve fro (B). Reaction conditions: The following reagents/reactants were
mixed in a centrifuge tube for synthesis of ieland–Miescher ketone: methanol (1 mL), methyl vinyl
ketone (81 µL), 2-methyl-1,3-cyclohexanedione (23 mg), deionized water (100 µL), and lipase (5 mg).
After reactant assembly, centrifuge tubes were placed in a shaker (30 ◦C, 250 rpm) for 48 h. Target mass
(m/z) = 178.10.
Reaction yields were determined for each lipase using a standard curve (Figure 2C and Table 1).
While we were able to identify lipases (Entries 1, 3, and 5 in Table 1) with biocatalytic activity, the yields
were less than 1%, in contrast to a literature report using these conditions [12]. As a result, we undertook
optimization studies using our top hit from the screen (L1-PPL) to attempt better reaction yields.
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Table 1. Screening of lipase library for synthesis of Wieland–Miescher ketone.
Entry Lipase Code Lipase Name Yield(ng/µL) a
1 L1 Porcine Pancreatic Lipase (PPL) 6140
2 L2 Rhizopus Oryzae 92
3 L3 Wheat Germ Lipase 2880
4 L4 Candida Rugosa 269
5 L5 Aspergillus Niger 591
6 L6 Aspergillus Oryzae 242
7 L7 Pseudomonas Cepacia 59
8 L8 Candida Sp. 148
9 L9 Rhizopus Niveus 457
10 L10 Mucor Miehei 211
11 L11 Mucor Javanicus 331
12 L12 Candida Antarctica “B” 15
13 L13 Candida Antarctica “A” 77
14 L14 Pseudomonas Fluorescens 648
a Yields determined by LC/MS.
To optimize this reaction, we turned to a previously described one-pot synthesis of WMK using
L-proline in DMSO [18]. Therefore, in these initial optimization studies, we switched to DMSO as the
primary solvent and included L-proline as a positive control. In the optimization experiments, reaction
yields were assessed using HPLC (Figure 3C). We found that the PPL-catalyzed reaction in DMSO
produced the triketone product 13 (Figure 3A), whereas the L-proline reaction formed the expected
WMK products 3 and 4 (Figure 3A). We hypothesized that L-proline plays dual roles as a biocatalyst:
one in which the amino acid promotes the necessary transition state for conversion of 13 to 14 through
an aldol addition, and another in which the α-amino sidechain functions as a base to convert 14 to a
mixture of products 3 and 4 through dehydration. Therefore, we reasoned that addition of a basic
co-catalyst such as imidazole might better mimic the bi-functional L-Pro catalyst. We found that a
combination of PPL and imidazole was able to produce a modest yield of 3 and 4 (Figure 3 and Table 2).
By contrast, in reactions in which only PPL was present, or in which only imidazole was present,
no WMK product was detected via HPLC (Figure 3B and Table 2). Interestingly, the combination of
BSA and imidazole also resulted in an appreciable yield of product (Table 2).
Table 2. Addition of imidazole as cocatalyst for reaction optimization.
Entry Biocatalyst Cocatalyst (Imidazole) Yield (%) a
1 - - n.r.
2 - + n.r.
3 PPL (5 mg) - 2.6
4 PPL (5 mg) + 14.4
5 BSA (5 mg) - n.r.
6 BSA (5 mg) + 13.4
7 L-Pro (6.4 mg) - 68.8
a Yields were determined by HPLC; n.r., no reaction/product not detected by HPLC.
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2.1. Reaction Optimization: Catalyst Loading, Solvent Effects, Enantiomeric Excess
Having identified the components necessary for forming modest amounts of WMK from protein
and co-catalyst, we sought to further optimize the reaction by focusing on catalyst loading and
solvent system. Setting up a series of reactions in DMSO, we varied catalyst loading from 5 to
35 mg/mL, finding that reaction yield increased up to 30 mg of catalyst per 1 mL reaction volume,
but decreased with amounts in excess of 30 mg (Table 3 and Figure 4A). The observed decrease in
yield with higher catalyst loading is largely due to an increased amount of insoluble, aggregated
material from the crude lipase preparation in the reaction vials, which interferes with efficient mixing
of the lipase and substrates. Note that mechanical stirring, rather than shaking, might reverse the
observed trend. We then investigated reaction yields in solvents other than DMSO. Reactions in
methanol produced similar yields to DMSO, yet reactions with increasingly longer chain alcohols
(ethanol, propanol, butanol, and pentanol) steadily decreased reaction yields (Table 3). Enantiomeric
excess of the Wieland–Miescher ketone products produced with the lipase/imidazole system in DMSO
were substantially lower than those produced with L-Proline (Figure 4), whereas performing the
PPL reaction in MeOH slightly improved enantiomeric excess. Reactions performed in longer chain
alcohols also resulted in progressively lower enantiomeric excess (ee) values (Table 3, Entries 6–9).
Table 3. Determination of optical purity for reactions with PPL and imidazole.
Entry Biocatalyst Solvent Yield (%) a Ee (%) b
1 L-Proline DMSO 68.8 70.1
2 PPL-5 mg DMSO 14.4 9.8
3 PPL-35 mg DMSO 51.9 17.7
4 PPL-5 mg Methanol 7.3 24.1
5 PPL-30 mg Methanol 55.1 21.7
6 PPL-30 mg Ethanol 48.3 10.3
7 PPL-30 mg Propanol 35.3 8.3
8 PPL-30 mg Butanol 28.7 6.1
9 PPL-30 mg Pentanol 29.6 3.6
a Yields were determined by HPLC. b Enantiomeric excess (ee) determined by chiral HPLC; S-configuration.
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(see Materials and Methods). The higher molecular weight species was identified as porcine alpha-
amylase, whereas the lower molecular weight species was identified as a porcine carboxypeptidase 
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L-Proline and PPL/imidazole catalyzed WMK reactions. (A) PPL/imidazole reactions in DMSO with
varying amounts of PPL catalyst. Chiral HPLC chromatograms (Chiralcel OD-H column; mobile phase:
isopropanol/heptane mixture (20/80, v/v) containing 0.1% formic acid) are shown for: (B) racemic
WMK standard; (C) S-WMK enriched standard; (D) R-WMK enriched standard; (E) purified L-proline
catalyzed WMK product; and (F) purified PPL/imidazole catalyzed WMK product.
2.2. Reaction Optimization: Exploration of Co-Catalysts
We next investigated the effects of co-catalysts other than imidazole on reaction yield.
Dimethylaminopyridine (DMAP), which is more nucleophilic but less basic than imid zole, gave a
substantially lower yield (Table 4, Entry 4). Alternately, i nic base co-cataly ts sodiu hydroxide and
odium bicarb nate gave less significantly reduced yields of WMK
Table 4. Screening optimal PPL loading with different cocatalyst and solvents.
Entry Cocatalyst Solvent Yield(%) a
1 Sodium Hydroxide Methanol 43.0
2 Sodium Bicarbonate Meth l 46.5
3 Imidazole Methanol 55.1
4 DMAP Methanol 24.5
a Yields were determined by HPLC.
2.3. Determination of Primary Components of Biocatalytic Preparations
Previous rep rts have de onstrated the presence of multiple biocatalytic entities present in
commonly used lipase preparations [19]. Having optimized our reaction conditions with crude lipase
preparations, we sought to more precisely define their composition. We separated the crude PPL mixture
on a size exclusion column, isolating two primary components (Figure 5A). Bands were excised and
subjected to proteolytic digest and subsequent characterization by mass spectrometry (see Section 4).
The higher molecular weight species was identified as porcine alpha-amylase, whereas the lower
molecular weight species was identified as a porcine carboxypeptidase (both carboxypeptidases A1 and
B were present in the analysis). Surprisingly, neither of the principle components of this commonly used
lipase preparation was porcine pancreatic lipase. This is significant, since numerous reports use this
preparation of porcine pancreatic lipase (Type II), and others without further purification [12,14,20,21].
A second lipase from our library with biocatalytic activity for WMK production (L3; wheat germ lipase)
Catalysts 2020, 10, 1063 7 of 13
was also characterized by this method (Figure 5B and Supplementary Materials Figure S1). Again,
none of the principle components of this preparation was identified as wheat germ lipase.
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Figure 5. Identification of components of lipase L1 (Porcine Pancreatic Lipase) and L3 (Wheat Germ
L pas ) preparat ons. (A) PPL lipase preparation was purified using size exclusion chromatography.
The fractions were also analyzed u ing SDS-PAGE and two distinct bands were found to be present in
the crude preparation of PPL and were subsequently characterized by m ss spect ometry fingerprinting
a alysis. (B) Pe tides identified in the fingerp int analysis i dicated that the band with lower molecular
weight (PPL, Low MW; blue rectangle, Lan 3 in (A)) contained two proteins Carboxypeptidase A1
and Carb xypeptidase B) and the band with higher molecular weight (PPL, High MW; blue rectangle,
Lane 6 in (A)) contained the p otein Alpha-amylase. Electrophoretic mobility f the Lo MW band
corresponds to the mature (truncated) forms of Carboxypeptidase A1 and B. An identical analysis was
conducted for the Wheat Germ Lipase (WGL) protein preparation, resulting in the identification of
HSP70 and Phosphoglycerate kinase (only two of many T. aestivu proteins present in this re arati ,
see Figure S1). The namesake “porcine pancreatic li ase” or “wheat germ lipase” were not identified as
principal components in either analysis.
2.4. Reassessment of Biocatalytic Preparations with Optimized Reaction Conditions
H ving identified optimized solve t, catalys loading, and basic cofactor, we then rescreened
our lipase library for biocatalytic activity towards WMK. In addition, as an outcome of this screen,
we discovered that absorbance, in addition to mass spec, could be an effective means of screening
for biocatalytic potential towards the WMK synthesis. In addition to select lipases from our initial
screen, we also included commercially available proteins that were identified by proteomics as
principal components of the crude PPL preparation (carboxypeptidase A (PA), carboxypeptidase
B (PB), alpha amylase (P alphaS)) in addition to immobilized forms of Candida antarctica lipase
B (L12-acr and L12-imo). By correlating absorbance (350 nm) of the crude reaction mixture with
reaction yield (Figure 6A), we demonstrate a correlation between biocatalytic potential and yield
of WMK. Furthermore, plotting absorbance (350 nm) versus percent yield reveals that applying
a colorimetric cutoff of OD350 = 1.0 would eliminate all of the reactions with yields below 10%
(Figure 6B). This indicates that colorimetric analysis could be a convenient basis for a large-scale screen
of biocatalysts for WMK production.
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Figure 6. Rescreening of the lipase library under optimized conditions. (A) Images of reactions
after 89 h (top); absorbance of crude reaction mixtures at 350 nm (middle); and reaction yields from
rescreening of each the lipase library (bottom). Error bars determined from three replicate HPLC
injections. (B) Wavelength scan of crude reaction absorbance. (C) Plot of absorbance (350 nm) versus
reaction yield.
A more in-depth analysis of reaction yields from this screen reveals that the biocatalysts identified
in the initial LC/MS screen (L1, L3, L5, L9, and L14) also emerged as top biocatalysts in the colorimetric
screen (Figure 6 and Table 5). In addition, alpha amylase alone, which was identified as a primary
component of the PPL preparation, produced a significant yield of WMK. The yield did not match
that of the crude PPL preparation, indicating that multiple proteinaceous components, including
porcine pancreatic lipase, carboxypeptidases, and amylases, may be involved in the biocatalytic
reaction. However, based on the ability of a non-lipase protein (BSA) and an individual amino acid
(L-Pro) to promote product formation, we hypothesized that the endogenous catalytic activities of the
component proteins were likely not contributing to product formation. To investigate this possibility,
we then conducted our biocatalytic reactions in the presence of amylase and lipase inhibitors (acarbose
and orlistat, respectively; Table 6). In the presence of excess inhibitor, the yield of the PPL reaction
was essentially unchanged. Similarly, the yield of the reaction with the amylase component was
only modestly reduced in the presence of excess inhibitor. We also confirmed that intrinsic lipase
activity of the PPL preparation was fully inhibited in the presence of orlistat by monitoring hydrolytic
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activity with p-nitrophenylpalmitate with and without inhibitor (Figure S2). Based upon these results,
we conclude that lipase activity is not responsible for the promiscuous catalysis observed with crude
preparations of PPL. Furthermore, while the reaction can be catalyzed by multiple proteinaceous
entities regardless of whether they possess intrinsic enzymatic activity, not all proteins are capable of
catalyzing product formation.
Table 5. Rescreening of lipase library using optimized reaction conditions.
Entry Biocatalyst Yield (%) a ee (%) b
1 L1 51.9 21.7
2 L3 17.1 1.2
3 L5 13.5 19.9
4 L9 16.0 14.4
5 L14 10.9 (−)1.7
6 α-Amylase(solid) 26.4 19.3
a Yields were determined by HPLC; n.r., no reaction. b Determined by chiral HPLC (insert column information
here); S-configuration.
Table 6. Addition of catalyst inhibitors
Entry Biocatalyst Inhibitor (Acarbose) Inhibitor (Orlistat) Yield (%) a
1 PPL - - 50.7
2 PPL + - 52.5
3 PPL - + 54.9
4 α-Amylase (solid) - - 31.0
5 α-Amylase (solid) + - 27.4
6 α-Amylase (solid) - + 27.6
a Yields were determined by HPLC.
3. Discussion
In this study, we screened lipase preparations for catalysis of a one-pot Wieland–Miescher
ketone synthesis. Our initial screen detected minimal product formation in the presence of lipases
alone. As a result, we turned to literature conditions used in the L-Pro catalyzed WMK synthesis
for reaction optimization purposes. We found that inclusion of a basic co-catalyst was essential for
promoting higher yields of WMK in the presence of a protein catalyst, in contrast to the L-Pro catalyzed
reaction, which requires no co-catalyst. In addition, we used proteomics to characterize the primary
components of a crude lipase mixture that has been previously used in numerous studies of biocatalysis.
We anticipate that these results will inform future studies using this catalytic preparation. After further
optimizing catalyst loading and solvent conditions, we then re-screened a lipase library, correlating
absorbance of the crude reaction mixture with production of WMK product. This approach could
easily be expanded to screen larger libraries of potential biocatalysts. Finally, we demonstrated that the
innate enzymatic activities of the proteins present are not required for product formation. While the
identification of the essential catalytic moieties remains incomplete, it appears that future optimization
work might best be focused on alternative considerations, such as shape complementarity and surface
exposed sidechains, rather than the native catalytic mechanisms of these promiscuous biocatalysts.
For example, the poorer enantioselectivity of protein biocatalysts versus the individual amino acid
L-Pro is intriguing, suggesting that the presence of a well-defined active-site cavity contributes little to
stabilization of the transition state. However, the advantages of a protein biocatalyst over an individual
amino acid catalyst (more engineerable, more adaptable to immobilization, etc.) support future
engineering efforts of these nascent catalytic entities. Furthermore, as not all lipase preparations tested
in this screen supported promiscuous biocatalytic activity, there are protein preparation-dependent
aspects of this biocatalytic synthesis that require further investigation.
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Promiscuity in biocatalysis remains an intriguing topic, often challenging chemists to think
outside the comfort zone of well-established catalytic mechanisms. In this work, we demonstrated
that the assumptions regarding the role of intrinsic catalytic properties of promiscuous biocatalysts
should be carefully considered. In many studies, catalytic promiscuity has undoubtedly been
misattributed to various properties of one enzyme or another, when the role of surface exposed
amino acids, protein shape, or even influence of the dielectric environment may be more important.
For promiscuous biocatalysts to fulfill their potential as inexpensive and reusable “green” reagents,
it is critical that their modes of action be more precisely characterized. For example, in this study,
we identified alpha amylase as a key catalytic component of a crude lipase preparation from porcine
pancreas. As a result, future studies can now be conducted on the optimization of this protein for
promiscuous biocatalysis through rational design, directed evolution, or exploration of immobilization
methodologies. Furthermore, this study established that colorimetric screening can be useful for
identifying catalysts of WMK formation. In addition to this being a general platform for identifying
new biocatalysts, we anticipate that this screen can be extended to other variations on the Robinson
annulation, enabling screening for substrate scope.
4. Materials and Methods
Chemicals, substrates, and solvents were purchased from commercial sources (Millipore-Sigma
(St. Louis, MO, USA); TCI America (Portland, OR, USA); VWR (Radnor, PA, USA); and Fisher Scientific,
Waltham, MA, USA). Lipases, amylases, and carboxypeptidases were purchased from Sigma-Aldrich
(St. Louis, MO, USA). Bovine serum albumin (BSA) was purchased from Fisher Scientific (see Table 7).
LC/MS mass spectrometry method. Liquid chromatography (LC) was performed on a HPLC system
(3200 Exion LC100; SCIEX Corporation, Framingham, MA, USA). Five microliters of samples were
injected into the reversed-phase Gemini NX-C18 column (50 mm × 2.0 mm, 3 µm; Phenomenex,
Torrance, CA, USA) by using auto sampler. The mobile phase composition for A was water/acetonitrile
mixture (95/5, v/v) with 0.1% formic acid, and for B was methanol. The gradient method was as follows:
100% A for 1 min, decrease to 15% over 4 min, hold at 15% for 1 min, increase back to 100% over 1 min,
and hold at 100% for 3 min. The flow rate was 0.3 mL min−1 and total run time was 10 min for each
sample injection. The column temperature was kept at 35 ◦C. The LC elute was introduced into the
Applied Biosystem Triple Quad API 3200, a triple-quadrupole tandem mass spectrometer (Beverly,
MA, USA) equipped with a turbo spray ionization source, for quantification of compounds in positive
ionization mode. Detection of the target molecule was performed in a multiple reaction monitoring
(MRM) mode, and transition of m/z 179.24 to 161.20 was used for detection of WMK.
Biocatalysis general conditions. The following reagents/reactants were mixed in a microcentrifuge
tube for synthesis of Wieland–Miescher ketone: solvent (900 µL), methyl vinyl ketone (19.8 µL),
2-methyl-1,3-cyclohexanedione (20 mg), deionized water (100 µL), and lipase (0–40 mg) or L-proline
(6.4 mg), with or without imidazole (2.7 mg, 0.04 mmol). For reaction involving inhibitors,
the biocatalyst was mixed with the inhibitor (5 mg) for 10 min at room temperature before adding
the substrates and cocatalyst. After reaction assembly, capped microcentrifuge tubes were placed in a
temperature-controlled shaker (New Brunswick Excella e24; 35 ◦C, 250 rpm) for 89 h.
Cofactor and cosolvent optimization. The following reagents/reactants were mixed in a
microcentrifuge tube for synthesis of Wieland–Miescher ketone: alcohol solvent (900 µL), methyl vinyl
ketone (19.8 µL), 2-methyl-1,3-cyclohexanedione (20 mg), deionized water (100 µL), lipase (L1, 30 mg),
and cocatalyst (0.04 mmol). After reaction assembly, capped microcentrifuge tubes were placed in a
temperature-controlled shaker (New Brunswick Excella e24; 35 ◦C, 250 rpm) for 89 h.
Lipase purification and proteomics. Solutions of porcine pancreatic lipase and wheat germ lipase were
fractionated on a HiPrep 26/60 Sephacryl S-200 HR column connected to an Akta FPLC (GE Healthcare
Life Sciences, city, State Abbr. (if has), country). Protein fractions were characterized via SDS-PAGE
gels stained with SimplyBlue SafeStain (ThermoFisher). The bands of greatest intensity were excised
and digested with trypsin overnight using a standard in-gel digestion protocol. The resultant
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tryptic peptides were desalted using a C18 Zip-Tip and applied to a MALDI target plate with
α-cyano-4-hydroxycinnamic acid as the matrix. The sample was analyzed on an AB Sciex 5800 MALDI
TOF/TOF mass spectrometer (Framingham, MA, USA). MS/MS spectra were searched against Uniprot
databases using Mascot version 2.3 (Matrix Science) (Boston, MA, USA) within ProteinPilot software
version 3.0 (AB Sciex, Framingham, MA, USA). A significance score threshold was calculated in Mascot,
with ion scores above the threshold considered positive IDs (p < 0.05).
Table 7. Lipase library components a.
Lipase Code Lipase Catalog Number
L1 Porcine Pancreatic Lipase (PPL) * L3126
L2 Rhizopus Oryzae * 62305
L3 Wheat Germ Lipase * L3001
L4 Candida Rugosa * L1754
L5 Aspergillus Niger * 62301
L6 Rhizomucor miehei ** L4277
L7 Pseudomonas Cepacia * 62309
L8 Candida Sp. ** L3170
L9 Rhizopus Niveus * 62310
L10 Mucor Miehei * 62298
L11 Mucor Javanicus * L8906
L12 Candida Antarctica B ** 62288
L13 Candida Antarctica A ** 62287
L14 Pseudomonas Fluorescens * 534730
L12-acr Candida Antarctica B ** L4777
L12-imo Candida Antarctica B ** 52583
PA Carboxypeptidase A * C9268
PB Carboxypeptidase B * C9584
P alpha Alpha amylase (suspension) * 10102814001
P alpha S Alpha amylase (powder) * A3176
a Lipase library components were purchased from Sigma-Aldrich. Catalog numbers are shown for rapid identification
of lipases. * Indicates lipases extracted from native biological source; ** indicates lipase produced in a non-native
host (i.e., recombinant).
Hi-Res Mass Spec analysis of triketone and WMK. Samples were analyzed with a Q Exactive
HF-X (ThermoFisher, Bremen, Germany) mass spectrometer. Samples were introduced via a heated
electrospray source (HESI) at a flow rate of 10 µL/min. One hundred times domain transients
were averaged in the mass spectrum. HESI source conditions were set as: nebulizer temperature
100 deg C, sheath gas (nitrogen) 15 arb, auxiliary gas (nitrogen) 5 arb, sweep gas (nitrogen) 0 arb,
capillary temperature 250 ◦C, RF voltage 100 V, and spray voltage 3.5 KV. The mass range was set
to 150–2000 m/z. All measurements were recorded at a resolution setting of 120,000. Solutions were
analyzed at 0.1 mg/mL or less based on responsiveness to the ESI mechanism. Xcalibur (ThermoFisher,
Breman, Germany) was used to analyze the data. Molecular formula assignments were determined
with Molecular Formula Calculator (v 1.2.3). All observed species were singly charged, as verified by
unit m/z separation between mass spectral peaks corresponding to the 12C and 13C12Cc-1 isotope for
each elemental composition.
Characterization of triketone (2-methyl-2-(3-oxobutyl)-1,3-cyclohexanedione): Hi-Res mass spec:
m/z = 197.11761 (mass error = 2.0 ppm) Assigned Chemical Formula: C11H17O3 [M+H]+; 1H-NMR
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(400 MHz, CDCl3): 2.60–2.77 (m, 4H), 2.35 (t, 2H), 2.11 (s, 3H), 2.04–2.08 (m, 2H), 1.89–1.95 (m, 2H),
1.25 (s, 3H).
Characterization of WMK ((S,R)-(+/−)-8a-methyl-3,4,8,8a-tetrahydro-1,6(2H,7H)-naphthalenedione):
Hi-Res mass spec: m/z = 179.10583 (mass error = −4.6 ppm) Assigned Chemical Formula: C11H15O2
[M+H]+; 1H NMR (400 MHz): 5.85 (s, 1H), 2.67–2.76 (m, 2H), 2.38–2.52 (m, 4H), 2.09–2.19 (m, 3H),
1.65–1.78 (m, 1H), 1.45 (s, 3H).
HPLC analysis of reaction yield. Liquid chromatography was performed on a HPLC system
(Waters Corporation, Milford, MA, USA) consisting of a binary pump (1525 Binary HPLC Pump),
absorbance detector (2487 Dual Wavelength Absorbance Detector), and auto sampler (717-plus Autosampler).
Five microliters of sample were injected into the reversed-phase Xterra MS C18 column (4.6 mm × 100 mm,
5 µm; Waters, Milford, MA, USA) using the auto sampler. The samples were analyzed using an isocratic
method: 80% Solvent A (water) and 20% Solvent B (methanol). The flow rate was 1.0 mL min−1 and the
total run time was 13 min for each sample injection. The detector wavelength was set to 210 nm and the
retention time for WMK was 7.9 min.
HPLC analysis of enantiomeric excess. Liquid chromatography for enantiomeric excess was performed on
a HPLC system (Waters Corporation) consisting of binary pump (1525 Binary HPLC Pump), absorbance
detector (2487 Dual Wavelength Absorbance Detector), and auto sampler (717-plus Autosampler).
Five microliters of sample were injected into the Chiralcel OD-H column (0.46 cm × 25 cm; Daicel,
Minato, Japan) using the auto sampler. Isopropanol/heptane mixture (20/80, v/v) containing 0.1% formic
acid was used as a mobile phase at a flow rate of 0.1 mL min−1. Total run time was 111 min for each sample
injection. The detector wavelength was set to 250 nm and the retention times for (S)-WMK and (R)-WMK
were 43.5 and 46.3 min, respectively.
5. Conclusions
We characterized the biocatalytic potential of commercially available lipase preparations for catalysis
of Wieland–Miescher ketone synthesis. Optimization experiments demonstrated the importance of a basic
co-catalyst for efficient production of Wieland–Miescher ketone. Enantioselectivities were lower than a
previously reported L-Pro catalyzed WMK synthesis. We were also able to identify non-lipase proteins present
in a commercially available lipase preparation with biocatalytic activity and establish a colorimetric screen for
identification of biocatalysts. Taken together, these methods comprise a potential platform for future engineering
studies, where biocatalysts identified in this work can be optimized for better yields, enantioselectivities,
and substrate scope in WMK synthesis and in related carbon–carbon bond forming reactions.
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